This company has been marked as potentially delisted and may not be actively trading. CARGO Therapeutics (CRGX) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsEarningsFDA EventsHeadlinesInsider TradesOwnershipTrendsBuy This Stock Get the Latest News and Ratings for CRGX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for CARGO Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CRGX Analyst Ratings Over TimeTypeCurrent Forecast9/22/24 to 9/22/251 Month Ago8/23/24 to 8/23/253 Months Ago6/24/24 to 6/24/251 Year Ago9/23/23 to 9/22/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy0 Buy rating(s)0 Buy rating(s)0 Buy rating(s)7 Buy rating(s)Hold6 Hold rating(s)6 Hold rating(s)6 Hold rating(s)0 Hold rating(s)Sell1 Sell rating(s)1 Sell rating(s)1 Sell rating(s)0 Sell rating(s)Consensus Price Target$15.40$15.40$15.00$30.33Forecasted Upside244.52% Upside244.52% Upside258.85% Upside27.18% UpsideConsensus RatingReduceReduceReduceBuy CRGX Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History CRGX Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table CARGO Therapeutics Stock vs. The CompetitionTypeCARGO TherapeuticsMedical CompaniesS&P 500Consensus Rating Score 1.86 2.78 2.53Consensus RatingReduceModerate BuyModerate BuyPredicted Upside244.52% Upside14,947.87% Upside11.30% UpsideNews Sentiment RatingNeutral NewsSee Recent CRGX NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails7/8/2025Jefferies Financial Group2 of 5 starsMichael Yee Not RatedBoost TargetHold$3.70 ➝ $5.00+8.93%1/30/2025Chardan Capital1 of 5 starsGeulah Livshits3 of 5 starsDowngradeBuy ➝ Neutral1/30/2025Piper Sandler2 of 5 starsBiren Amin Not RatedDowngradeOverweight ➝ Neutral$34.00 ➝ $4.00-69.67%1/30/2025William BlairSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingS. CorwinSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeOutperform ➝ Market Perform1/30/2025JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBrian ChengSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeOverweight ➝ Underweight1/30/2025Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingAsthika GoonewardeneSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeBuy ➝ Hold$32.00 ➝ $7.00-46.93%1/30/2025HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingRobert BurnsSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeBuy ➝ Neutral12/5/2023TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Initiated CoverageOutperformAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 03:47 AM ET. CRGX Forecast - Frequently Asked Questions What is CARGO Therapeutics' forecast for 2025? According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for CARGO Therapeutics is $15.40, with a high forecast of $33.00 and a low forecast of $4.00. Should I buy or sell CARGO Therapeutics stock right now? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CARGO Therapeutics in the last twelve months. There is currently 1 sell rating and 6 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "reduce" CRGX shares. Does CARGO Therapeutics's stock price have much upside? According to analysts, CARGO Therapeutics's stock has a predicted upside of 244.52% based on their 12-month stock forecasts. What analysts cover CARGO Therapeutics? CARGO Therapeutics has been rated by research analysts at Jefferies Financial Group in the past 90 days. Do Wall Street analysts like CARGO Therapeutics more than its competitors? Analysts like CARGO Therapeutics less than other "medical" companies. The consensus rating for CARGO Therapeutics is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CRGX compares to other companies. Stock Forecasts and Research Tools Related Companies Praxis Precision Medicines Stock Forecast Urogen Pharma Stock Forecast Iovance Biotherapeutics Stock Forecast Immunome Stock Forecast Taysha Gene Therapies Stock Forecast uniQure Stock Forecast Phathom Pharmaceuticals Stock Forecast Tango Therapeutics Stock Forecast Anavex Life Sciences Stock Forecast Niagen Bioscience Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:CRGX) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | SponsoredThis soon could be the most precious company in AmericaAI is devouring power at an unprecedented rate. Google alone expects its annual electricity bill to jump by $2...True Market Insiders | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CARGO Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CARGO Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
